BRAINBox Solutions™ multi-modality approach is led by the leaders in the industry. It will include blood biomarker panels available on a point of care instrument and standard laboratory systems, as well as neurocognitive testing, to provide objective evidence of injury and prediction of patient recovery.
Location: United States, Virginia, Richmond
Employees: 11-50
Total raised: $23M
Founded date: 2018
Investors 5
Date | Name | Website |
- | CAV Angels | cavangels.... |
10.02.2021 | Genoa Vent... | genoavc.co... |
- | Astia Ange... | astia.org |
- | BioVenture... | bioventure... |
- | VTC Innova... | vtcventure... |
Funding Rounds 1
Date | Series | Amount | Investors |
08.12.2020 | Series A | $23M | - |
Mentions in press and media 5
Date | Title | Description |
01.05.2023 | VIPC’s Virginia Venture Partners Invests in BRAINBox Solutions For Accurate Diagnosis of Mild Traumatic Brain Injury | AI-Based product uses blood biomarker panels to provide a comprehensive solution to Traumatic Brain Injury Our brains define every aspect of who we are, so the consequences of a brain injury can affect all aspects of our lives. Even a commo... |
16.12.2020 | BRAINBox Solutions Announces Enrollment Begins in Pivotal, HeadSMART II Clinical Study of BRAINBox TBI Concussion Diagnostic and Prognostic Test | |
08.12.2020 | BRAINBox Solutions Announces First Close in $23 Million in Series A Financing to Support Development and Pivotal Clinical Trial of 'Breakthrough' Concussion Diagnostic/Prognostic Test | |
08.12.2020 | BRAINBox Solutions Closes $23 Million in Series A Financing | BRAINBox Solutions today announced the initial closing on a $23 million Series A financing to support the clinical development of the company's BRAINBox TBI Test to aid both in the diagnosis and prognosis of mild TBI. BioVentures Investors ... |
- | BRAINBox | “At BRAINBox Solutions, our multi-modality approach aims to aid clinicians with the diagnosis of traumatic brain injury and what comes next.” |